Related references
Note: Only part of the references are listed.Local minima found in the subparameter space can be effective for ensembles of deep convolutional neural networks
Yongquan Yang et al.
PATTERN RECOGNITION (2021)
Analysis of tumor nuclear features using artificial intelligence to predict response to neoadjuvant chemotherapy in high-risk breast cancer patients
David W. Dodington et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Deep learning in cancer pathology: a new generation of clinical biomarkers
Amelie Echle et al.
BRITISH JOURNAL OF CANCER (2021)
Deep learning for prediction of colorectal cancer outcome: a discovery and validation study
Ole-Johan Skrede et al.
LANCET (2020)
Deep Learning Predicts Molecular Subtype of Muscle-invasive Bladder Cancer from Conventional Histopathological Slides
Ann-Christin Woerl et al.
EUROPEAN UROLOGY (2020)
Breast Cancer, Version 3.2020
William J. Gradishar et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
Predicting treatment response to neoadjuvant chemoradiotherapy in local advanced rectal cancer by biopsy digital pathology image features
Fang Zhang et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
Predicting survival from colorectal cancer histology slides using deep learning: A retrospective multicenter study
Jakob Nikolas Kather et al.
PLOS MEDICINE (2019)
A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients
Begona Pineda et al.
CLINICAL EPIGENETICS (2019)
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
Jakob Nikolas Kather et al.
NATURE MEDICINE (2019)
Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set
Elizabeth Hope Cain et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Predicting Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer Combined Statistical Modeling Using Clinicopathological Factors and FDG PET/CT Texture Parameters
Hyunjong Lee et al.
CLINICAL NUCLEAR MEDICINE (2019)
Artificial Intelligence Algorithms to Assess Hormonal Status From Tissue Microarrays in Patients With Breast Cancer
Gil Shamai et al.
JAMA NETWORK OPEN (2019)
Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy
Waqar Haque et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Nuclear shape and orientation features from H&E images predict survival in early-stage estrogen receptor-positive breast cancers
Cheng Lu et al.
LABORATORY INVESTIGATION (2018)
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
Carsten Denkert et al.
LANCET ONCOLOGY (2018)
Predicting cancer outcomes from histology and genomics using convolutional networks
Pooya Mobadersany et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Integrative cluster classification to predict pathological complete response to neoadjuvant chemotherapy in early breast cancer
Emilio Alba et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning
Nicolas Coudray et al.
NATURE MEDICINE (2018)
Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer
Babak Ehteshami Bejnordi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer
Laura Spring et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial
H. R. Ali et al.
ANNALS OF ONCOLOGY (2017)
Predicting breast cancer response to neoadjuvant chemotherapy using pretreatment diffuse optical spectroscopic texture analysis
William T. Tran et al.
BRITISH JOURNAL OF CANCER (2017)
Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients
Briete Goorts et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib
Lisa A. Carey et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis
Tarek M. A. Abdel-Fatah et al.
LANCET ONCOLOGY (2016)
High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer (vol 21, pg 150, 2016)
Emilio Alba et al.
ONCOLOGIST (2016)
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado et al.
ANNALS OF ONCOLOGY (2015)
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Patricia Cortazar et al.
LANCET (2014)
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2013)
Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response
E. H. Lips et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Response-Guided Neoadjuvant Chemotherapy for Breast Cancer
Gunter von Minckwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy
Nehmat Houssami et al.
EUROPEAN JOURNAL OF CANCER (2012)
Accelerating Identification and Regulatory Approval of Investigational Cancer Drugs
Laura J. Esserman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Systematic Analysis of Breast Cancer Morphology Uncovers Stromal Features Associated with Survival
Andrew H. Beck et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
Carsten Denkert et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Share Paper
